$TEAM

Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup

Atlassian (TEAM) and Doximity (DOCS) shares rose about 30% after earnings on Aug. 7, helped by stronger-than-expected adoption of their AI offerings, according to the article. Both companies run vertical SaaS platforms and were viewed as potential AI losers. The piece also highlights GitLab (GTLB), UiPath (PATH), and Asana (ASAN) as potential similar setups ahead of upcoming results.

Original reporting
Published Aug 11, 2026, 6:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 6:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup — source image
Decision brief

The 30-second read

$TEAMBullishLow
01

Why it matters

The only concrete, company-specific trading catalyst described is the Aug. 7 post-earnings surge for TEAM and DOCS. For GTLB, PATH, and ASAN, the article is primarily a forward-looking thesis with no new event disclosed.

02

Market read

Traders get a momentum read-through for AI-enabled vertical SaaS after two large post-earnings reactions, but the rest is speculative setup framing without new disclosures.

03

What to watch

No details are given on margins, retention, net revenue retention, or the magnitude of guidance changes, which are typically what determine whether a 30% move sustains.

Relevance 4/10Novelty 3/10Timing: after-hours/next-session momentum from Aug. 7 earnings reaction; setup discussion for upcoming earnings

Background

The piece frames Atlassian and Doximity as AI-skeptic turnarounds after earnings, then lists three other SaaS names as potential similar setups.

Company-level read

Ticker impact

$TEAMBullishMedium confidence
Context

Atlassian shares surged more than 30% after earnings, with the article attributing the move to strong AI adoption and guidance.

Expected impact

Near-term momentum likely remains elevated, but follow-through depends on the next earnings setup the article only frames qualitatively.

Evidence & confidence

The text clearly links the jump to AI adoption and guidance, yet it does not disclose specific new KPIs, guidance figures, or analyst actions that would enable a precise trade plan.

$DOCSBullishMedium confidence
Context

Doximity jumped over 30% after earnings, and the article says strong adoption of its AI offerings helped drive results and guidance.

Expected impact

Momentum bias remains positive, but conviction is limited because the article lacks incremental, report-specific metrics.

Evidence & confidence

The article provides a concrete catalyst (earnings reaction) and causal attribution (AI adoption), but no new quantitative disclosures beyond the magnitude of the move.

$GTLBNeutralLow confidence
Context

The article uses GitLab as a potential “same setup” trade, citing a shared bear case around AI agents reducing seat licenses and a shift to usage-based models.

Expected impact

Limited immediate impact; any trade would be speculative and dependent on upcoming earnings rather than new information today.

Evidence & confidence

No new GitLab-specific earnings, guidance, or filings are disclosed; the piece is comparative and forward-looking.

$PATHNeutralLow confidence
Context

UiPath is presented as a potential earnings pop setup, with the article highlighting high short interest and a valuation backdrop plus an agentic AI orchestration pitch.

Expected impact

Potential upside is conditional on upcoming results; near-term trading value is low without a new event or datapoint.

Evidence & confidence

The only concrete facts are short-interest and valuation references, and the rest is thesis-based speculation for future earnings.

$ASANNeutralLow confidence
Context

Asana is included as another “same setup” name, with the article citing its pivot to enterprise, cost cuts, and AI Studio/AI Teammates plus an Anthropic integration.

Expected impact

Any trade would be thesis-driven into the next earnings cycle rather than reactionary to new information.

Evidence & confidence

The article does not report new Asana earnings, guidance, or a discrete corporate event; it mainly argues why the setup could repeat.

Market effects

Reinforces a broader SaaS narrative that AI adoption and hybrid/usage monetization can re-rate vertical workflow platforms.

No specific regional macro linkage is provided.

No direct global demand or regulatory linkage is disclosed.

Counterpoint

The article may overfit the “AI adoption” explanation to a large one-day move, while ignoring that the next earnings could disappoint if AI traction does not translate into durable revenue acceleration.

Key entities

  • Atlassian

    Enterprise workflow SaaS whose shares surged over 30% after earnings, attributed to strong AI adoption and guidance.

  • Doximity

    Clinical workflow SaaS whose shares surged over 30% after earnings, attributed to strong AI adoption and guidance.

  • GitLab

    DevSecOps platform discussed as a potential similar AI/monetization setup into upcoming earnings.

  • UiPath

    RPA platform discussed as a potential earnings pop candidate with high short interest and an agentic AI orchestration pitch.

  • Asana

    Project management SaaS discussed as a potential earnings upside setup via enterprise pivot and AI Studio/Teammates.

Related articles

$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 FY2027 revenue of $156.6 million, up 7% year over year, with adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million and adjusted EBITDA guidance to $309 million to $329 million. It also repurchased $91.6 million of stock and ended June 30 with $688 million cash and marketable securities.

$TEAMMedAI 8/10

Atlassian (TEAM) Q4 2026 Earnings Call Transcript

Atlassian (TEAM) reported Q4 FY2026 revenue of $1,766 million, up 28% YoY, driven by cloud and enterprise expansion. Cloud revenue was $1,213 million, up 31%. Subscription ARR was $6.6 billion (+23%), RPO $4.8 billion (+44%), and non-GAAP operating margin 36%. Q1 FY27 revenue guidance is $1,705-$1,715 million.

$DOCSMed

Doximity Stock Surges in Overnight Trading as Chief Executive Highlights High-Margin AI Tool

Doximity (DOCS) shares jumped in overnight trading after CEO Jeffrey Tangney said the company’s new AI search tool generates over 10 times the revenue versus its operating cost. The stock later closed up 33% on Friday. Doximity reported Q1 revenue of $156.6M and adjusted EBITDA of $74.8M, and raised full-year guidance to $671M-$681M. Wells Fargo later downgraded to underweight.